LGT Group Foundation’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-586
Closed -$204K 290
2025
Q4
$204K Sell
586
-415
-41% -$140K ﹤0.01% 286
2025
Q3
$333K Sell
1,001
-555
-36% -$173K ﹤0.01% 249
2025
Q2
$605K Sell
1,556
-551
-26% -$222K 0.01% 224
2025
Q1
$916K Sell
2,107
-40,557
-95% -$16.3M 0.01% 206
2024
Q4
$15.7M Sell
42,664
-29,924
-41% -$12.5M 0.24% 67
2024
Q3
$36.7M Buy
72,588
+343
+0.5% +$183K 0.6% 41
2024
Q2
$39.1M Sell
72,245
-380
-0.5% -$201K 0.62% 40
2024
Q1
$37.7M Sell
72,625
-5,084
-7% -$2.53M 0.89% 35
2023
Q4
$36.4M Sell
77,709
-2,240
-3% -$1.04M 0.8% 35
2023
Q3
$35.2M Buy
79,949
+6,424
+9% +$2.91M 0.87% 27
2023
Q2
$32.7M Buy
73,525
+37,589
+105% +$17.3M 0.79% 26
2023
Q1
$16.5M Buy
35,936
+521
+1% +$248K 0.47% 52
2022
Q4
$18.2M Sell
35,415
-1,380
-4% -$701K 0.57% 41
2022
Q3
$16.7M Buy
36,795
+889
+2% +$425K 0.65% 39
2022
Q2
$17.3M Sell
35,906
-7,776
-18% -$3.85M 0.53% 47
2022
Q1
$21.8M Buy
43,682
+5,276
+14% +$2.41M 0.51% 46
2021
Q4
$17.8M Buy
+38,406
New +$16.2M 0.46% 47

Other funds holding ELV

LGT Group Foundation's ELV Position: Q1 2026 in Review

LGT Group Foundation sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 586 shares — an estimated $204K sold.

LGT Group Foundation first reported a position in ELV in Q4 2021 and held it in 17 quarters. The position peaked at $39.1M in Q2 2024. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • LGT Group Foundation reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • LGT Group Foundation sold 586 Elevance Health shares in Q1 2026, an estimated $204K.
  • LGT Group Foundation first reported a position in Elevance Health in Q4 2021 and held it in 17 quarters.
  • LGT Group Foundation's Elevance Health position peaked at $39.1M in Q2 2024.
  • 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.